Accession Number: | 0001209191-21-052546 |
Date: | 2021-08-18 |
Issuer: | CIDARA THERAPEUTICS, INC. (CDTX) |
Original Submission Date: |
STEIN JEFFREY
6310 NANCY RIDGE DRIVE
SUITE 101
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-08-18 | P | 40,000 | a | $1.72 | 405,878 | direct | ||
COMMON STOCK | 2021-08-19 | P | 10,000 | a | $1.79 | 415,878 | direct | ||
COMMON STOCK | 2021-08-18 | 0 | $0.00 | 231,602 | indirect | ||||
COMMON STOCK | 2021-08-18 | 0 | $0.00 | 42,009 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the price reported in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $1.6990 to $1.7300, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. |
f2 | includes 4,000 shares acquired pursuant to the issuer's employee stock purchase plan on may 20, 2021. |
f3 | the price reported in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $1.7850 to $1.7899, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities andexchange commission, upon request, full information regarding the number of shares purchased at each separate price within the range setforth above. |